Avineuro Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

Avineuro General Information

Description

Developer of small molecules designed to fulfill the unmet medical needs in neurology and psychiatry. The company's molecules combine modern medicinal chemistry with streamlined pre-clinical and clinical development studies, enabling healthcare providers to cure the neurological disease of the patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 1835 East Hallandale Beach Boulevard
  • Suite 442
  • Hallandale Beach, FL 33009
  • United States
+1 (786)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1835 East Hallandale Beach Boulevard
  • Suite 442
  • Hallandale Beach, FL 33009
  • United States
+1 (786)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avineuro Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Feb-2021 Completed Clinical Trials - Phase 2
2. Early Stage VC 01-Oct-2013 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Avineuro’s complete valuation and funding history, request access »

Avineuro Patents

Avineuro Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-8552005-B2 (en) 3-sulfonyl-pyrazolo[1,5-a] pyrimidines / antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof Active 24-Jan-2008
US-20100331347-A1 (en) 3-sulfonyl-pyrazolo[1,5-a] pyrimidines / antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof Active 24-Jan-2008
EP-2248815-A2 3-sulfonyl-pyrazolo[1,5-a]pyrimidines / antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof Active 24-Jan-2008
EP-2248815-A4 3-sulfonyl-pyrazolo[1,5-a]pyrimidines / antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof Active 24-Jan-2008
EP-2248815-B1 3-sulfonyl-pyrazolo[1,5-a]pyrimidines / antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof Inactive 24-Jan-2008 C07D487/04
To view Avineuro’s complete patent history, request access »

Avineuro FAQs

  • When was Avineuro founded?

    Avineuro was founded in 2008.

  • Where is Avineuro headquartered?

    Avineuro is headquartered in Hallandale Beach, FL.

  • What industry is Avineuro in?

    Avineuro’s primary industry is Drug Discovery.

  • Is Avineuro a private or public company?

    Avineuro is a Private company.

  • What is Avineuro’s current revenue?

    The current revenue for Avineuro is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process